Cargando…

Corrigendum to: Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia

Detalles Bibliográficos
Autores principales:	Šálek, Tomáš, Friedecký, Bedřich, Kratochvíla, Josef, Pelinková, Květa, Budina, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Society of Medical Biochemistry and Laboratory Medicine 2019
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784419/ https://www.ncbi.nlm.nih.gov/pubmed/31624467 http://dx.doi.org/10.11613/BM.2019.031202

Ejemplares similares

Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia
por: Tomáš, Šálek, et al.
Publicado: (2019)

Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia
por: Šálek, Tomáš, et al.
Publicado: (2023)

Survey on request form content and result reporting in therapeutic drug monitoring service among laboratories in Czechia and Slovakia
por: Šálek, Tomáš, et al.
Publicado: (2020)

Evaluating the feasibility of the KDIGO CKD referral recommendations
por: Singh, Karandeep, et al.
Publicado: (2017)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

What is being done to respond to the rise of chronic diseases and multi-morbidity in Czechia, Hungary, Poland, and Slovakia?
por: Sagan, Anna, et al.
Publicado: (2023)

Erratum to: Multiple imputation is better than KDIGO guidelines for estimating unknown baseline renal function
por: Jamme, Matthieu, et al.
Publicado: (2016)

Physicians’ Recognition and Management of Kidney Disease: A Randomized Vignette Study Evaluating the Impact of the KDIGO 2012 CKD Classification System
por: Hallan, Stein I., et al.
Publicado: (2020)

Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD
por: Mann, Johannes F. E., et al.
Publicado: (2021)

From KDIGO 2012 towards KDIGO 2021 in idiopathic membranous nephropathy guidelines: what has changed over the last 10 years?
por: Stai, Stamatia, et al.
Publicado: (2022)

KDIGO Board Members
Publicado: (2012)

Impact on Outcomes across KDIGO-2012 AKI Criteria According to Baseline Renal Function
por: Acosta-Ochoa, Isabel, et al.
Publicado: (2019)

Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD
por: Burton, James O., et al.
Publicado: (2018)

Corrigendum to ’Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506’ Virus Research (2012) 165/1 [112-117]: Corrigendum
por: Carbajo-Lozoya, Javier, et al.
Publicado: (2022)

Effectiveness and safety profiling of zolpidem and acupressure in CKD associated pruritus an interventional study: Erratum
Publicado: (2021)

Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
por: Waijer, Simke W., et al.
Publicado: (2022)

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59
Publicado: (2017)

Corrigendum
Publicado: (2012)

Corrigendum
Publicado: (2012)

Corrigendum
Publicado: (2011)

Corrigendum
Publicado: (2017)

Corrigendum
Publicado: (2020)

Corrigendum
Publicado: (2022)

Corrigendum
Publicado: (2018)

Corrigendum
Publicado: (2022)

Corrigendum
Publicado: (2022)

Corrigendum
Publicado: (2021)

The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines
por: Kitiyakara, Chagriya, et al.
Publicado: (2012)

Recovery from AKI by KDIGO criteria
por: Schrijvers, D, et al.
Publicado: (2014)

Gender Inequalities in the Health of Immigrants and Workplace Discrimination in Czechia
por: Dzúrová, Dagmar, et al.
Publicado: (2014)

Physiotherapy in Parkinson's Disease: Building ParkinsonNet in Czechia
por: Gal, Ota, et al.
Publicado: (2017)

Health Disparities in Czechia and Portugal at Country and Municipality Levels
por: Lustigova, Michala, et al.
Publicado: (2019)

Exploring neoliberal resilience: the transnational politics of austerity in Czechia
por: Šitera, Daniel
Publicado: (2021)

The characteristics of women not-attending screening and their barriers to attendance in Czechia
por: Altová, A, et al.
Publicado: (2022)

Corrigendum notice
Publicado: (2023)

Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal
por: Rojas-Rivera, Jorge Enrique, et al.
Publicado: (2019)

KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
Publicado: (2017)

Erratum to: Homicide in Chile: Trends 2000 – 2012
por: Otzen, Tamara, et al.
Publicado: (2016)

Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results
por: de Lusignana, Simon, et al.
Publicado: (2013)

Erratum to: The role of a low glomerular density and being overweight in the etiology of proteinuria in CKD patients without known glomerular diseases
por: Okamoto, Hidekazu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hv5v0mj30dup5j7f9ca773phfj